BioLabs | TUM

🎟️ #GoldenTicket Opportunity Innovation in migraine therapeutics is taking center stage! 💡 AbbVie is now accepting applications for its Golden Ticket program — a unique initiative supporting early-stage biotech ventures across the U.S. and Europe. 🌟 What’s included: 🔬 One year of lab bench + office space at BioLabs 🧠 Mentorship and R&D guidance from AbbVie scientists 🤝 Access to BioLabs’ vibrant network of founders and investors 💡 You keep 100% of your IP — no equity, no strings 🚀 Plus, the chance to explore collaboration with AbbVie 📅 Timeline Applications close: November 7, 2025 Finalists announced: November 21, 2025 Pitch event: December 8, 2025 Startups in the U.S., France, or Germany working on novel migraine therapies — this is your chance to shine. 👉 Apply now: https://lnkd.in/erJks6rp

Last week we had the chance to step inside the future of biotech innovation in Munich during a hardhat tour of the upcoming BioLabs | TUM facility ! This new biotech incubator will soon open in Munich to empower scientists and entrepreneurs to transform cutting-edge ideas into real-world solutions. We’re proud to take this step with the trust of strong partnerships: TUM Venture Labs driving academic entrepreneurship, and Lilly Deutschland GmbH bringing their commitment to advancing life sciences globally. Thank you also to Judith Gerlach for her support to TUM Venture Labs and this joint initiative, and to Goodwin for their sponsorship of the event.   Exciting times ahead for Munich’s biotech ecosystem, and we can’t wait to see the first startups move in !   #biotech #innovation #startups #munich   Maria Sievert Josef Braun Verena Stocker Johannes Fruehauf Juliane Winkelmann Markus Kaepplinger Johanna Michielin Clément Lapierre

🚨 Pitch at Berlin Bio Innovation Day – Apply by August 12 Are you building something bold in biotech or medtech? Then this is your opportunity to take the stage at Berlin Bio Innovation Day, happening on September 23 at CIC Berlin. Startups selected to pitch will: 🎤 Present live in front of more than 250 investors, industry leaders, and ecosystem players 💥 Join a private bootcamp ahead of the event, featuring top VCs, legal advisors, and scientific experts 🤝 Receive targeted 1:1 feedback and make strategic connections to accelerate your venture 👉 Apply by August 12: https://lnkd.in/dVJhzAyM If you’re not pitching but would like to attend the event, you can register here: 🎟️ https://lu.ma/6i7ghz7z Berlin Bio Innovation Day is co-hosted by #CLIC (Clinical Incubator at the Berlin Institute of Health in der Charité) and Nucleate Germany, with the support of our BioLabs community. Let’s spotlight the next generation of biotech and medtech innovation. BioLabs France BioLabs Heidelberg Garima Bhardwaj, Ph.D. Nico Alavi Aarón Xerach Herrera Martín Hannah Payette Peterson Jiexuan Jiang Stefan Hristov Komali Valishetti,PhD. #BerlinBioInnovationDay #CLIC #BiotechStartups #MedTech #PitchOpportunity

The FAZ spotlights the launch of BioLabs | TUM  in a dedicated article ! As highlighted by Johannes Fruehauf, the choice of Munich as the next location of BioLabs is due to its pioneering role in the biotechnology sector. Furthermore, our strong collaboration with major academic and industrial partners (respectively TUM Venture Labs and Lilly Deutschland GmbH) well implanted in Munich will only reinforce our impact ! 📰 Read the full article here: https://lnkd.in/ec_j7jCr

We’re proud to announce the launch of BioLabs | TUM: a new innovation hub opening end of 2025, in partnership with TUM Venture Labs and Lilly Deutschland GmbH.   With 1,800 sqm of fully equipped labs and offices, BioLabs | TUM will support 15–20 early-stage biotech startups by combining world-class infrastructure with tailored mentorship and access to global scientific and venture networks.   But what truly sets this project apart is the partnership behind it: 🔹 BioLabs, bringing its proven coworking lab model to Munich 🔹 TUM Venture Labs, translating cutting-edge science into scalable ventures 🔹 Lilly Deutschland GmbH, advancing early innovation through its Catalyze360™ model   Together, we’ve crafted a space where biotech startups will have the infrastructure, community, and connections they need to bring the next wave of therapies to life.   📖 Curious about the full story? 👉 https://lnkd.in/eGAg6_s2   More than a facility, it’s a shared mission — powered by people driving real change in biotech: Johannes Fruehauf | Philipp Gerbert | Johanna Michielin | Clément Lapierre | Giulia Mariatti | Valentina Zaburunova | Miriam Becker | Maria Sievert | Verena Stocker | Dr. Nicolai Heinzelmann | Katrin Blank | Chris Railey | Jasmin Eigemann   #BioLabsTUM #BuiltForBiotech #MunichInnovation #LifeSciences #DeepTechGermany #LillyCatalyze360 #TUMVentureLabs #StartupEcosystem #BioLabsEurope #Biotech #Innovation

One of the best aspects of working on the European expansion of BioLabs is that the team is always expanding ! As we are working on our next opening in #Munich, we are going to need a Lab Manager, in charge of our state-of-the-art shared labs. If you want to build the lab of your dreams, ensure scientific excellence, and provide hands-on support to startups, apply here ! 👇